Table 1. Baseline characteristics and final diagnoses of patients who underwent EUS-FNA.
Patients | Number | 81 |
Age at EUS-FNA | Median (range) | 70.0 (34–84) |
Sex | Male | 47 |
Female | 34 | |
Pancreatic mass location | Head | 35 (43.2%) |
Body | 26 (32.1%) | |
Tail | 20 (24.7%) | |
Final diagnosis | PDAC | 62 |
NET | 2 | |
SPN | 2 | |
IPMA/N | 2 | |
Benign | 13 |
EUS-FNA, endoscopic ultrasound fine needle aspiration; PDAC, pancreatic ductal adenocarcinoma; NET, neuroendocrine tumor; SPN, solid pseudopapillary neoplasm; IPMA/N, intraductal papillary mucinous adenoma/neoplasms.